Debmalya (Hrsg.) Barh
Cancer Biomarkers
Minimal and Noninvasive Early Diagnosis and Prognosis
Ebook (PDF Format)
Gleaning information from more than 100 experts in the field of cancer diagnosis, prognosis, and therapy worldwide, Cancer Biomarkers: Non-Invasive Early Diagnosis and Prognosis determines the significance of clinical validation approaches for several markers. This book examines the use of noninvasive or minimally invasive molecular cancer m
CHF 110.30
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
Versandkostenfrei
Produktdetails
Weitere Autoren: Carpi, Angelo (Hrsg.) / Verma, Mukesh (Hrsg.) / Gunduz, Mehmet (Hrsg.)
- ISBN: 978-1-4665-8429-7
- EAN: 9781466584297
- Produktnummer: 16968814
- Verlag: Taylor & Francis Ltd.
- Sprache: Englisch
- Erscheinungsjahr: 2014
- Seitenangabe: 951 S.
- Plattform: PDF
- Masse: 67'570 KB
Über den Autor
Debmalya Barh (MSc, MTech, MPhil, PhD, PGDM) is the founder and president of the Institute of Integrative Omics and Applied Biotechnology (IIOAB), India. He is a consultant biotechnologist and an active researcher in integrative omics-based biomarkers, targeted drug discovery, and personalized medicine in cancer, neurodisorders, and cardiovascular, infectious, and metabolic diseases. He works with nearly 400 esteemed researchers from 30-35 countries and he has more than 100 high-impact publications. He has edited ten books in the field of omics. He also serves as an editorial and review board member for several highly respected international journals.Dr. Angelo Carpi is a clinical professor of medicine at the Pisa University Medical School, Pisa, Italy. He received his MD and postgraduate diplomas in internal medicine and nuclear medicine from the University of Pisa and his diploma of qualification on peptide hormones from the Collegio Medico Giuridico-Scuola Normale Superiore and the Scuola Superiore Sant'Anna, Pisa, Italy. His clinical practice and research included thyroid and breast tumors. He has authored about 300 publications included in PubMed. He is a member of the editorial boards of international journals such as Biomedicine & Pharmacotherapy and Frontiers in Bioscience.Dr. Mukesh Verma is a program director and chief in the Methods and Technologies Branch (MTB), Epidemiology and Genomics Research Program (EGRP) of the Division of Cancer Control and Population Sciences (DCCPS) at the National Cancer Institute (NCI), National Institutes of Health (NIH). Dr. Verma received his MSc from Pantnagar University and his PhD from Banaras Hindu University. He did postdoctoral research at George Washington University and was a faculty member at Georgetown University. He has published 128 research articles, book chapters, and reviews, and has edited three books
40 weitere Werke von Debmalya (Hrsg.) Barh:
Minimal and Noninvasive Early Diagnosis and Prognosis
Ebook (PDF Format)
CHF 81.25
Minimal and Noninvasive Early Diagnosis and Prognosis
Ebook (PDF Format)
CHF 253.50
Minimal and Noninvasive Early Diagnosis and Prognosis
Ebook (EPUB Format)
CHF 167.70
Minimal and Noninvasive Early Diagnosis and Prognosis
Ebook (PDF Format)
CHF 133.50
Minimal and Noninvasive Early Diagnosis and Prognosis
Ebook (EPUB Format)
CHF 192.20
Minimal and Noninvasive Early Diagnosis and Prognosis
Ebook (EPUB Format)
CHF 225.75
Minimal and Noninvasive Early Diagnosis and Prognosis
Ebook (EPUB Format)
CHF 139.30
Minimal and Noninvasive Early Diagnosis and Prognosis
Ebook (PDF Format)
CHF 110.30
Minimal and Noninvasive Early Diagnosis and Prognosis
Ebook (EPUB Format)
CHF 206.40
Minimal and Noninvasive Early Diagnosis and Prognosis
Ebook (EPUB Format)
CHF 206.40
Minimal and Noninvasive Early Diagnosis and Prognosis
Ebook (EPUB Format)
CHF 225.75
Minimal and Noninvasive Early Diagnosis and Prognosis
Ebook (EPUB Format)
CHF 119.90
Minimal and Noninvasive Early Diagnosis and Prognosis
Ebook (PDF Format)
CHF 140.60
Minimal and Noninvasive Early Diagnosis and Prognosis
Ebook (PDF Format)
CHF 192.20
Minimal and Noninvasive Early Diagnosis and Prognosis
Ebook (PDF Format)
CHF 187.50
Bewertungen
0 von 0 Bewertungen
Anmelden
Keine Bewertungen gefunden. Seien Sie der Erste und teilen Sie Ihre Erkenntnisse mit anderen.